EMBL

DECIPHER v11.39 is now available, featuring enhanced N=1 variant assessments and new UKCGG clinical guidelines

A recent EMBO workshop brought together researchers who are expanding our understanding of how layers of genetic and epigenetic regulation underlie critical brain functions.

A milestone release: This is the final release on the current Ensembl platforms. From summer 2026, all new data will be accessible from the new site at beta.ensembl.org, which hosts over 5,200 genomes across animals, plants, bacteria, archaea, and fungi. The current Ensembl platforms will remain…

The Tara Coral expedition studies coral resilience with resulting data to be made available in EMBL-EBI resources.

Using AI to speed up the interpretation of missense variants and support drug discovery

EMBL and partners carried out a new TREC pilot project in Luxembourg to study how freshwater microbiomes respond to environmental change. By sampling rivers, soils, and wastewater sites along the Moselle and Rhine, researchers aim to provide a way to track ecosystem stress and pollution.

EMBL is coordinating STARDAST, a new €8M Horizon Europe project to strengthen data stewardship careers, FAIR data practices, and open science across Europe.

The new Head of Administration at EMBL Rome talks about her vision for creating a stable and supportive operational environment, and the importance of leading with clarity, consistency, and compliance.

Scientists find that close interactions between the mechanical properties of tissues and biochemical signalling between cells drive critical cell fate decisions during zebrafish embryo development.

EMBL-UNESCO fellows reflect on experiences at EMBL that broadened their own research capacity while providing new perspectives to collaborators.

EMBL-EBI’s new Team Leader shares her experience managing open data resources and rapidly growing biological data.

EMBL-EBI enables global productivity gains worth £11.8bn per year and powers AI-driven science and innovation at scale.

First open-source release of SIFTS for residue-level mapping between protein sequences and structures

A newly identified protein, SNOR, has been found to help cells in a starvation-induced dormancy restart protein synthesis once nutrients are again available.

EMBL-EBI and collaborators release a step-by-step guide to making research compliant with the Nagoya Protocol.

Headquartered in Tokyo – with a European Research facility in Munich – the company focuses on developing and delivering innovative new medicines, alongside advanced drug discovery and delivery methodologies, which serve patients globally. CPP members benefit from direct connection with EMBL’s world-leading molecular biology research, services, and technology development, and their support enables…

An international consortium has found over 1,700 new proteins from noncoding DNA, many of which show potential as targets for cancer immunotherapy.

The Marquez Team has developed an AI-based training method that automates crystal screening and identification for macromolecular crystallography studies.

Sharing genomic and clinical data through DECIPHER helps clinicians identify rare diseases faster, provides answers to families, and enables scientists to advance clinical understanding of these conditions

EMBL scientists are finding new and interesting ways to engage the public and make the wonders of scientific discoveries more accessible to everyone.